RxDoctor Payments Data

Daniel Bender, PA

Physician Assistant · Orbisonia, PANPI 1265736664

Payments from drug & device makers

$10,049in general payments, 2019–2025

Across 698 payments — averaging $14.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$3K
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$1K
  • Takeda Pharmaceuticals U.S.A., Inc.$1K
  • Johnson & Johnson$1K
  • Ardelyx, Inc.$714
  • Gilead$297
  • plus $2K from 23 others

What the payments were for

  • Food & beverage$9,92999%
  • Education$1201%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$10,049 in reported general payments places this provider in the 95th percentile of 6,643 physician assistant providers in Pennsylvania.

See all physician assistant providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$30,973
Medicare patients
271
Services billed
334

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
StelaraUstekinumab18$494,055
CreonLipase/Protease/Amylase78$187,057
LinzessLinaclotide129$100,735
XifaxanRifaximin23$74,074
IbsrelaTenapanor Hcl15$32,116
TrulancePlecanatide40$29,446
Mesalamine40$24,006
Dexlansoprazole DrDexlansoprazole85$20,551
ViberziEluxadoline15$18,076
Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates236$15,234
Pantoprazole Sodium852$10,973
Lubiprostone70$9,187
Sucralfate109$8,467
Omeprazole566$7,369
Mesalamine ErMesalamine16$7,298

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonStelara$1,065$494,05518 claims
AbbVieCreon, Linzess, Viberzi$3,092$305,868222 claims
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan, Trulance$1,488$103,52063 claims
Ardelyx, Inc.Ibsrela$714$32,11615 claims
Braintree Laboratories, Inc.Sutab$122$3,27021 claims
Ferring Pharmaceuticals Inc.Clenpiq$67$2,49815 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 6,643 physician assistant providers in Pennsylvania.

Other physician assistant in Orbisonia

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →